FDA announces a public workshop titled “Identification of Concepts and Terminology for Multi-Component Biomarkers
March 23, 2020
8:00 AM – 5:00 PM ET
FDA, White Oak Campus, The Great Room
10903 New Hampshire Avenue
Silver Spring, MD 20903
The Food and Drug Administration (FDA) will hold a public workshop titled “Identification of Concepts and Terminology for Multi-Component Biomarkers” on March 23, 2020 at FDA’s White Oak Campus. The purpose of the public workshop is to address the need to identify standardized high-level conceptual terminology, its potential hierarchy, and include specific language to describe the range of multi-component biomarkers and their application to decision-making.
Learn more and Register